NCT00133692View on ClinicalTrials.gov

INVEST: INternational VErapamil SR Trandolapril STudy

PHASE4CompletedINTERVENTIONAL
Enrollment

22,000

Participants

Timeline

Start Date

September 30, 1997

Study Completion Date

February 28, 2003

Conditions
HypertensionCoronary Artery Disease
Interventions
DRUG

Verapamil SR/Trandolapril/Hydrochlorothiazide (HCTZ)

DRUG

Atenolol/HCTZ/Trandolapril

Trial Locations (1)

32610-0277

University of Florida, Gainesville

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

University of Florida

OTHER